U.S. puts $1 billion toward development of H1N1 flu vaccine

05/25/2009 | Wall Street Journal, The

The HHS said the government is earmarking $1 billion to fund clinical trials this summer for an H1N1 swine flu vaccine and to produce two bulk components of the vaccine for stockpiling in case an extensive vaccination program is needed. The government agreed to provide funding to Novartis, Sanofi-Aventis and GlaxoSmithKline to manufacture the vaccine ingredients.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA